Concepedia

Publication | Open Access

External validation suggests Integrin beta 3 as prognostic biomarker in serous ovarian adenocarcinomas

DOIFull Paper Access

21

Citations

30

References

2009

Year

Karolina Partheen, Kristina Levan, Lovisa Österberg, Ingela Claesson, Karin Sundfeldt, György Horváth
BMC Cancer

Abstract

The loss of ITGB3 expression in tumours from deceased patients and high expression in tumours from survivors could be used as a biomarker for patients with advanced serous tumours.

References

YearCitations

Page 1